发明名称 |
Implantable systems and methods for monitoring myocardial electrical stability by detecting PVC induced T-wave alternans reversals |
摘要 |
Embodiments of the present invention relate to implantable systems, and methods for use therewith, for assessing a patients' myocardial electrical stability. Implanted electrodes are used to obtain an electrogram (EGM) signal, which is used to identify periods when the patient experiences T-wave alternans. Additionally, the EGM signal is used to determine whether premature ventricular contractions (PVCs) cause phase reversals of the T-wave alternans. The patient's myocardial electrical stability is assessed based on whether, and in a specific embodiment the extent to which, PVCs cause phase reversals of the T-wave alternans. This abstract is not intended to be a complete description of, or limit the scope of, the invention. |
申请公布号 |
US8996102(B2) |
申请公布日期 |
2015.03.31 |
申请号 |
US201113149549 |
申请日期 |
2011.05.31 |
申请人 |
Pacesetter, Inc. |
发明人 |
Farazi Taraneh Ghaffari |
分类号 |
A61N1/37;A61B5/0452;A61N1/36;A61N1/362;A61N1/39 |
主分类号 |
A61N1/37 |
代理机构 |
|
代理人 |
Rayner Theresa A. |
主权项 |
1. In an implantable system, a method for assessing a patients' myocardial electrical stability, comprising:
(a) obtaining an electrogram (EGM) signal using implanted electrodes; (b) identifying, based on the EGM, periods when the patient experiences T-wave alternans; (c) determining, based on the EGM, whether premature ventricular contractions (PVCs) cause phase reversals of the T-wave alternans; (d) assessing the patient's myocardial electrical stability based on an extent to which PVCs cause phase reversals of the T-wave alternans; and (e) triggering a response based on the results of step (d), wherein the response involves delivering anti-arrhythmia therapy, wherein the response, if a PVC causes a phase reversal of the T-wave alternans, further includes charging a capacitor, in case the patient goes into ventricular fibrillation and needs therapy. |
地址 |
Sunnyvale CA US |